BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Biochemistry of Hallucinogens: Native\, Clinical and Recreatio
 nal Uses | Psychopharmacology Speaker Series Webinar
X-WR-TIMEZONE:Pacific Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260616T221008Z
UID:tag:localist.com\,2008:EventInstance_52649044528547
DTSTART:20260722T000000Z
DTEND:20260722T010000Z
DESCRIPTION:Hallucinogens are a diverse class of psychoactive substances th
 at alter perception\, mood\, and cognition by interacting with specific ne
 urotransmitter systems in the brain\, most notably the serotonin 5-HT2A re
 ceptor. Effects arise from disruptions in cortical network connectivity an
 d modulation of thalamic sensory gating\, leading to a more fluid and less
  filtered flow of information between brain regions. While historically as
 sociated with recreational use\, current research has explored their poten
 tial therapeutic applications in treating depression\, anxiety\, PTSD\, an
 d addiction\, highlighting both their powerful neurochemical effects and t
 he importance of controlled\, supportive settings for safe use. While cere
 monial use often involves careful dosing and cultural safeguards\, recreat
 ional or unsupervised use particularly with poly-drug interactions can sig
 nificantly increase the risk of toxicity. Interactions between different h
 allucinogens with serotonin-enhancing medications (SSRIs\, MAOIs\, SNRIs\,
  lithium) will be discussed in relation to pharmacotherapeutic toxicity fr
 om Serotonin Syndrome.\n\nDr. Judi Steinman is an adjunct professor in All
 iant University’s Master of Science in Clinical Psychopharmacology (MSCP
 ) program and was Program Director from 2017-2022. She served as the Presi
 dent of APA’s Society for Prescribing Psychology (Division 55) in 2019 a
 nd as Past President from 2020-2022. She co-chairs the Division 55 Trainin
 g Program Director Council and is founding chair of the Division 55 Legisl
 ative and Social Action Committee (LASAC). She co-authored the Division’
 s Specialty Petition to APA’s CRSPPP\, allowing Clinical Psychopharmacol
 ogy to be recognized as a specialty. Dr. Steinman serves as chair of the H
 awaiʻi and Florida Psychological Associations’ RxP Committees. She is a
 ctively engaged in efforts to bring prescriptive authority for qualified p
 sychologists to Hawai`i\, Florida and across the globe. She trains graduat
 es from all of the MSCP programs for the national PEP exam.\n\n1.0 Continu
 ing Education Unit Available*\n\nRegister: alliantu.co/cspp0721\n\nFor que
 stions about accessibility or to request accommodations in order to fully 
 participate in this activity/event\, please contact the Office of Accessib
 ility at accessibility@alliant.edu or 858-635-4535. You will be contacted 
 by someone from our staff to discuss your specific needs.
LOCATION:
SUMMARY:Biochemistry of Hallucinogens: Native\, Clinical and Recreational U
 ses | Psychopharmacology Speaker Series Webinar
URL;VALUE=URI:https://events.alliant.edu/event/copy-of-the-science-vs-pseud
 oscience-of-medical-cannabis-what-clinicians-need-to-know-psychopharmacolo
 gy-speaker-series-webinar
CATEGORIES:Meetings & Info Sessions
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR